Assistant Professor, Department of Neurosurgery
University of Florida College of Medicine
Flores’ research interests are primarily in determining biological interactions between various cellular compartments involved in adoptive immunotherapy.
He Huang Ph.D.
Professor and Associate Dean
Zhejiang University School of Medicine
Hangzhou, China
Huang specializes in hematopoietic stem cell transplantation and hematology in clinic. He also focuses on hematological molecular biology, cellular immunotherapy and stem cell biology research.
Professor of Oncology, Department of Oncology Hematologic Malignancies,
Johns Hopkins University School of Medicine
The major research focus in the Luznik lab is the immunobiology of graft-versus-leukemia (GVL) responses and graft-versus-host disease (GVHD).
Professor of Medicine and Chief of the Division of Blood and Marrow Transplantation
Stanford University School of Medicine
Negrin’s research work has focused on cellular immunology in particular developing a more fundamental understanding of complex biological reactions such as graft versus host and graft vs tumor reactions in animal models and in the clinic.
Nataliya P. Buxbaum, M.D.
Assistant Clinical Investigator, Experimental Transplantation and Immunotherapy Branch
National Cancer Institute
Buxbaum’s research efforts are focused on understanding the biology of cGVHD through the use of pre-clinical models and evaluating pediatric patients on the Natural History of cGVHD study at the NCI.
Armin Rashidi, MD, PhD
Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation
University of Minnesota, Masonic Cancer Center
Rashidi’s research focuses on the microbiome and dysbiosis and acute graft-versus-host disease.
Director, Michael Cuccione Childhood Cancer Research Program, BC Children’s Hospital
Professor, Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, University of British Columbia
Schultz’s research group is attempting to harness the immune system to cure child leukemia and to use blood-derived stem cells to cure other life threatening childhood diseases. They focus on harnessing the immune forces unleashed by BMT to improve immune therapy for childhood leukemia.
Associate Professor of Medicine
Duke University, Duke Cancer Institute
Chen Lab | medicine.duke.edu
Reseach in the Chen lab focuses on experimental stem cell transplantation: GVHD/GVL, stem cell engraftment, induction of immune tolerance, novel applications.
Tessa Andermann, M.D., MPH
Assistant Professor, Division of Infectious Diseases
Assistant Professor of Medicine
University of North Carolina School of Medicine
Dr. Andermann’s research focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations
Stefanie Sarantopoulos, M.D., Ph.D.
Associate Professor of Medicine
Associate Professor of Immunology
Duke University, Duke Cancer Institute
A major goal of Dr. Sarantopoulos’ research is to develop effective and safe bone marrow transplant (also known as allogeneic stem cell transplantation, HCT) so that we can cure patients with refractory hematological malignancies. A major hindrance to long-term success of HCT is chronic graft versus host disease (cGVHD).
Robert Jenq, M.D.
Deputy Department Chair, Department of Genomic Medicine
Assistant Professor, Department of Genomic Medicine
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
The Jenq Laboratory examines the impact of the microbiome on cancer treatment, focusing in particular on bone marrow transplantation and cancer immunotherapies.
Ryotaro Nakamura, M.D.
Associate Professor,Department of Hematology & Hematopoietic Cell Transplantation
Associate Chair of the Cancer Protocol Review and Monitoring Committee
City of Hope
Nakamura’s research focuses on immunological interventions for hematological malignancies. Nakamura’s research broadly encompasses studies to augment immune responses against leukemia and infection while minimizing immune-related toxicities, such as GVHD.
Assistant Professor of Medicine, Department of Medicine
Hospital of the University of Pennsylvania
Gill’s research expertise lies in tumor immunology, chimeric antigen receptor T cells, mouse models of human leukemia, murine xenografts, adoptive cellular therapy, genetic engineering of T cells and flow cytometry.
Elizabeth Thomas Professor of Medicine, Microbiology and Immunology
Director, Immunotherapy Program
Co-leader, Immunology Program,
UNC Lineberger Comprehensive Cancer Center
Serody’s laboratory is interested in the mechanism by which T cells and antigen presenting cells migrate into tissues to mediate their function.
Associate Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Romee’s long-term goals as a translational and academic researcher are to translate novel aspects of immunology to improve treatments for patients with hematologic malignancies.
Nora Letzter Professor of Pediatrics
Indiana University School of Medicine
Paczesny leads biomarker discovery and validation research for complications of hematopoietic cell transplantation including for graft-versus-host disease (GVHD).
Gerhard Hildebrandt, M.D.
Division Chief, Hematology and Blood & Marrow Transplantation
Professor of Medicine
University of Kentucky, Markey Cancer Center
Hildebrandt focuses on patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation and on patients suffering from acute and chronic graft versus host disease.